MYLI
UTHR icon

Meiji Yasuda Life Insurance’s United Therapeutics UTHR Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
3,612
+895
+33% +$504K 0.06% 93
2026
Q1 		$1.61M Buy
2,717
+1,200
+79% +$598K 0.06% 102
2025
Q4 		$739K Buy
+1,517
New +$706K 0.02% 152
2019
Q2 		– Sell
-2,433
Closed -$286K – 337
2019
Q1 		$286K Sell
2,433
-1,179
-33% -$137K 0.04% 293
2018
Q4 		$393K Sell
3,612
-788
-18% -$91.4K 0.06% 248
2018
Q3 		$563K Buy
4,400
+630
+17% +$77.9K 0.07% 240
2018
Q2 		$427K Buy
3,770
+230
+6% +$25.3K 0.06% 266
2018
Q1 		$398K Sell
3,540
-230
-6% -$29.2K 0.06% 265
2017
Q4 		$558K Buy
3,770
+1,910
+103% +$243K 0.08% 230
2017
Q3 		$218K Sell
1,860
-900
-33% -$115K 0.03% 297
2017
Q2 		$358K Buy
2,760
+100
+4% +$12.5K 0.06% 256
2017
Q1 		$360K Sell
2,660
-350
-12% -$53K 0.06% 245
2016
Q4 		$432K Sell
3,010
-310
-9% -$39.6K 0.07% 214
2016
Q3 		$392K Buy
3,320
+220
+7% +$26.4K 0.05% 257
2016
Q2 		$328K Buy
3,100
+280
+10% +$31.2K 0.05% 251
2016
Q1 		$314K Buy
2,820
+300
+12% +$38K 0.05% 256
2015
Q4 		$395K Buy
+2,520
New +$367K 0.06% 218

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Meiji Yasuda Life Insurance's UTHR Position: Q2 2026 in Review

Meiji Yasuda Life Insurance increased its United Therapeutics (UTHR) stake by 33% in Q2 2026, buying an estimated $504K and bringing the position to 3,612 shares worth $1.96M. The position accounts for 0.06% of the portfolio, ranked #93.

Meiji Yasuda Life Insurance first reported a position in UTHR in Q4 2015 and has held it in 17 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Meiji Yasuda Life Insurance held 3,612 shares of United Therapeutics worth $1.96M as of Q2 2026.
  • Meiji Yasuda Life Insurance bought 895 United Therapeutics shares in Q2 2026, an estimated $504K.
  • United Therapeutics made up 0.06% of Meiji Yasuda Life Insurance's portfolio in Q2 2026, its #93 holding.
  • Meiji Yasuda Life Insurance first reported a position in United Therapeutics in Q4 2015 and has held it in 17 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.